Skip to content

Net Change in Cash at other companies

Eli Lilly logo
Eli LillyLLY
-$1.99B-1,035%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
$10.73M+207%
Opko Health logo
Opko HealthOPK
-$27.18M-769%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$74.44M-49.3%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$37.44M-41.4%
Erasca, Inc. logo
Erasca, Inc.ERAS
-$26.55M-1,068%

Other financials

Income statement

See full
Operating income-$58.0M-66.3%
Net income-$53.1M-74.7%
EPS (diluted)-$0.52-44.4%

Balance sheet

See full
Cash & equivalents$52.5M+3.8%
Total debt$956.0K-16.7%
Total equity$480.5M+25.3%
Total assets$530.6M+29.5%

Cash flow

See full
Operating cash flow-$46.0M-4.6%
CapEx-
Free cash flow-$34.5M-27.8%

Valuation

See full
Market cap$973.05M+244%
Enterprise value$921.46M+295%

Returns & leverage

See full
Return on equity-42.9%+1.3pp
Debt / equity0.0×
Current ratio10.9×-4.3×

Where this comes from

Reported directly by Olema Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Olema Pharmaceuticals, Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Olema Pharmaceuticals, Inc.'s net change in cash?
Olema Pharmaceuticals, Inc. (OLMA) reported net change in cash of $4.25M in Q1 2026.
How has Olema Pharmaceuticals, Inc.'s net change in cash changed year-over-year?
Olema Pharmaceuticals, Inc.'s net change in cash increased by 104.8% year-over-year, from -$88.84M to $4.25M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.